Ignite Creation Date:
2024-05-06 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 2:22 PM
Study NCT ID:
NCT05194163
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-03-29
First Post:
2022-01-13
Brief Title:
MW150 Stress Kinase Inhibitor in Mild to Moderate Alzheimers Disease
Sponsor:
Neurokine Therapeutics
Organization:
Neurokine Therapeutics
Organization Data
Organization:
Neurokine Therapeutics
Class:
INDUSTRY
Study ID:
MW150-AD-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Neurokine Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Lawrence S Honig MD PhD FAAN
Responsible Party Title:
Professor of Neurology at Columbia University Irving Medical Center
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Columbia University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Columbia University | OTHER |
| National Institute on Aging NIA | NIH |